Britney Hess joined Ontario Genomics in 2016. In her current role, she manages OG’s investment portfolio and program which focuses on supporting companies that are commercializing genomics and engineering biology-based solutions. Britney supports the implementation of strategic initiatives aimed at bringing new genomic-derived solutions to the Industrial Biotechnology and Natural Resource sectors and she is the main point of contact for funded projects in these sectors. She has also been instrumental in assisting with the planning and implementation of several strategic initiatives including the launch and execution of the CanadaSynBio conferences.

Previously, Britney worked at Bioenterprise Corporation as a Junior Analyst in Agricultural Technologies. She performed needs-based-analysis and provided entrepreneurs with market, industry and competitor data specific to their innovative technology.

Britney earned her Bachelor’s and Master’s degrees from the University of Western Ontario. During her Master of Management of Applied Science (MMASc) she focused on an interdisciplinary approach to technology commercialization.